Dose-Escalated G-CSF Dose Not Improve Resolution of Neutropenia Compared to Standard-Dose G-CSF Following Autologous Stem Cell Transplantation

被引:0
|
作者
Trifilio, Steven [1 ]
Fong, Jessica I. [1 ]
Zhao, Cindy [1 ]
Zhang, Junyu [1 ]
Liu, Derek [1 ]
Villa, Marcelo [2 ]
Mehta, Jayesh [3 ]
机构
[1] NW Mem Hosp, Chicago, IL 60611 USA
[2] NW Mem Hosp, Cell Therapy Proc Facil, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.1016/j.bbmt.2014.11.157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
127
引用
收藏
页码:S122 / S123
页数:2
相关论文
共 50 条
  • [31] Peripheral blood stem cell mobilization in multiple myeloma (MM): High-dose cyclophosphamide plus G-CSF vs. G-CSF alone
    Goldschmidt, H
    Hegenbart, U
    Cremer, FW
    Kiel, K
    Moos, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 72 - 72
  • [32] Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).
    Berger, Elizabeth
    Seet, Christopher
    Parthasarathy, Mala
    Rodriguez, Tulio
    Smith, Scott E.
    Toor, Amir
    Lee, Mary
    Petrowsky, Cecilia
    Fox-Geiman, Mary
    Stiff, Patrick
    BLOOD, 2009, 114 (22) : 1250 - 1251
  • [33] Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery
    Ottosson, S
    Magnusson, K
    Hultborn, R
    ANTICANCER RESEARCH, 1999, 19 (5C) : 4429 - 4434
  • [34] Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
    R. I. Lalisang
    F. L. G. Erdkamp
    C. J. Rodenburg
    C. T. A. M. Knibbeler-van Rossum
    J. W. R. Nortier
    A. van Bochove
    P. H. Th. J. Slee
    E. E. Voest
    J. A. Wils
    J. Wals
    O. J. L. Loosveld
    A. E. M. Smals
    G. H. Blijham
    V. C. G. Tjan-Heijnen
    H. C. Schouten
    Breast Cancer Research and Treatment, 2011, 128 : 437 - 445
  • [35] Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy
    Lalisang, R. I.
    Erdkamp, F. L. G.
    Rodenburg, C. J.
    Knibbeler-van Rossum, C. T. A. M.
    Nortier, J. W. R.
    van Bochove, A.
    Slee, P. H. Th. J.
    Voest, E. E.
    Wils, J. A.
    Wals, J.
    Loosveld, O. J. L.
    Smals, A. E. M.
    Blijham, G. H.
    Tjan-Heijnen, V. C. G.
    Schouten, H. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 437 - 445
  • [36] Increased efficacy of intermediate-dose cytarabine plus G-CSF compared to DHAP plus G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the polish lymphoma research group
    Giebel, Sebastian
    Sadus-Wojciechowska, Maria
    Halaburda, Kazimierz
    Drozd-Sokolowska, Joanna
    Wierzbowska, Agnieszka
    Najda, Jacek
    Mendrek, Wlodzimierz
    Sobczyk-Kruszelnicka, Malgorzata
    Nowicki, Mateusz
    Holowiecki, Jerzy
    Czerw, Tomasz
    ANNALS OF HEMATOLOGY, 2016, 95 (02) : 263 - 269
  • [37] Prospective randomised study of PBSC mobilisation using intermediate dose cyclophosphamide and G-CSF versus G-CSF alone.
    Karanth, M
    Harvey, C
    Chakrabarti, S
    Holder, K
    McConkey, CC
    McDonald, D
    Lovell, RA
    Fegan, CD
    Milligan, DW
    BLOOD, 2002, 100 (11) : 826A - 826A
  • [38] VERY HIGH EFFICACY OF CYTARABINE plus G-CSF COMPARED TO CYCLOPHOSPHAMIDE plus G-CSF AS HEMATOPOIETIC STEM CELL MOBILIZATION IN PATIENTS WITH LYMPHOID MALIGNANCIES REFERRED FOR AUTOLOGOUS TRANSPLANTATION
    Kruzel, T.
    Czerw, T.
    Sadus-Wojciechowska, M.
    Najda, J.
    Glowala-Kosinska, M.
    Chwieduk, A.
    Holowiecki, J.
    Giebel, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 353 - 353
  • [39] Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
    Vazquez Meraz, Jose Eugenio
    Arellano-Galindo, Jose
    Martinez Avalos, Armando
    Mendoza-Garcia, Emma
    Jimenez-Hernandez, Elva
    STEM CELLS INTERNATIONAL, 2016, 2016